GSK-F1 (Compound F1) is an orally active PI4KA inhibitor with pIC 50 values of 8.0, 5.9, 5.8, 5.9, 5.9 and 6.4 against PI4KA, PI4KB, PI3KA, PI3KB, PI3KG and PI3KD, respectively. GSK-F1 can be used for HCV infection research.
性状
Solid
IC50 & Target[1][2]
PI4KA 8.0 (pIC50) PI4KB 5.9 (pIC50
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-20°C, sealed storage, away from moisture and light In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
参考文献
[1]. Bojjireddy N, et al. Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels. J Biol Chem. 2014 Feb 28;289(9):612
溶解度数据
In Vitro: DMSO : 125 mg/mL (207.12 mM; Need ultrasonic)配制储备液